Germany Pharmaceutical Logistics Market Forecast 2024-2032

The Germany pharmaceutical logistics market is anticipated to develop at a CAGR of 6.94% during the forecast period 2024-2032. Various enablers promote market growth, like the rising need for temperature-controlled solutions in pharmaceuticals, the expansion of ocean freight services in the pharmaceutical industry, the rise in consumer preference for over-the-counter medicines, and the surge in pharmaceutical logistics during the Germany COVID-19 pandemic.

MARKET INSIGHTS

The Germany pharmaceutical logistics market has witnessed a prominent rise in consumer preference for over-the-counter (OTC) medicines. This shift can be attributed to several factors, including increased awareness among consumers about self-medication options, convenience in accessing OTC products from pharmacies and online platforms, and the availability of a wide range of OTC medications for common health conditions. As consumers become more proactive in managing minor ailments and health concerns independently, the demand for efficient and reliable pharmaceutical logistics services to ensure timely delivery of OTC medicines has grown significantly.

Moreover, the COVID-19 pandemic has spurred a surge in pharmaceutical logistics activities within Germany. The pandemic highlighted the critical importance of an agile and resilient supply chain for pharmaceutical products, including vaccines, medications, and medical supplies. As healthcare systems and governments prioritized rapid response measures, pharmaceutical logistics providers faced unprecedented challenges in meeting increased demand, ensuring product integrity, and navigating supply chain disruptions. Despite these challenges, the pandemic also accelerated innovation in logistics technology and strategies, driving greater efficiency and adaptability in the Germany pharmaceutical logistics sector.

However, alongside these opportunities, the market faces key restraints, notably stringent regulatory requirements. The pharmaceutical industry operates within a highly regulated environment, with strict guidelines governing product handling, storage conditions, transportation protocols, and quality assurance standards. Compliance with regulatory requirements adds complexity and cost to logistics operations, requiring logistics providers to invest in specialized infrastructure, training, and adherence to Good Distribution Practice (GDP) guidelines. These regulatory hurdles can pose challenges for market players, impacting operational flexibility, scalability, and cost-effectiveness in pharmaceutical logistics.

COMPETITIVE INSIGHTS

Some of the major companies in the Germany pharmaceutical logistics market include Cencora (AmerisourceBergen), CEVA Logistics, Agility Logistics, Cardinal Health, etc.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation caters to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
The competitive landscape is the theoretical explanation of the key companies based on factors such as market share.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 85196

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. COUNTRY SNAPSHOT
2.3. COUNTRY ANALYSIS
2.4. SCOPE OF STUDY
2.5. CRISIS SCENARIO ANALYSIS
2.6. MAJOR MARKET FINDINGS
- 2.6.1. BRANDED DRUGS ARE THE MOST COMMONLY USED PRODUCTS IN THE PHARMACEUTICAL LOGISTICS MARKET
- 2.6.2. COMMUNICABLE DISEASES HOLD THE LARGEST MARKET SHARE IN THE THERAPY AREA
- 2.6.3. COLD CHAIN LOGISTICS IS THE FASTEST-GROWING TYPE WITHIN THE PHARMACEUTICAL LOGISTICS MARKET
- 2.6.4. MONITORING OF PHARMACEUTICAL LOGISTICS OPERATIONS IS INCREASINGLY BECOMING A FOCUS AREA

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. RISING NEED FOR TEMPERATURE-CONTROLLED SOLUTIONS IN PHARMACEUTICALS
- 3.1.2. EXPANSION OF OCEAN FREIGHT SERVICES IN PHARMACEUTICAL INDUSTRY
- 3.1.3. RISE IN CONSUMER PREFERENCE FOR OVER-THE-COUNTER MEDICINES
- 3.1.4. SURGE IN PHARMACEUTICAL LOGISTICS DURING THE GERMANY COVID-19 PANDEMIC
3.2. KEY RESTRAINTS
- 3.2.1. RIGOROUS REGULATORY REQUIREMENTS IN PHARMACEUTICAL LOGISTICS
- 3.2.2. ENSURING REAL-TIME TRANSPARENCY AND RELIABILITY IN PHARMACEUTICAL LOGISTICS

4. KEY ANALYTICS

4.1. KEY MARKET TRENDS
- 4.1.1. SURGE IN DEMAND FOR CELL & GENE THERAPY LOGISTICS
- 4.1.2. REVOLUTIONIZING PHARMACEUTICAL LOGISTICS THROUGH DIGITAL TRANSFORMATION
- 4.1.3. INCREASING CLINICAL TRIALS LOGISTICS DEMANDS
4.2. PORTER'S FIVE FORCES ANALYSIS
- 4.2.1. BUYERS POWER
- 4.2.2. SUPPLIERS POWER
- 4.2.3. SUBSTITUTION
- 4.2.4. NEW ENTRANTS
- 4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
- 4.3.1. GROWTH PROSPECT MAPPING FOR GERMANY
4.4. MARKET CONCENTRATION ANALYSIS
4.5. VALUE CHAIN ANALYSIS
- 4.5.1. MANUFACTURING
- 4.5.2. STORAGE
- 4.5.3. TRANSPORTATION
- 4.5.4. DISTRIBUTION
- 4.5.5. MONITORING COMPONENTS
- 4.5.6. CONSUMPTION
4.6. KEY BUYING CRITERIA
- 4.6.1. TYPE OF LOGISTICS
- 4.6.2. SERVICES OFFERED
- 4.6.3. MODE OF TRANSPORTATION
- 4.6.4. APPLICATION
- 4.6.5. REGULATORY COMPLIANCE
- 4.6.6. TECHNOLOGICAL CAPABILITIES
- 4.6.7. COST
- 4.6.8. RELIABILITY
- 4.6.9. AGILITY

5. MARKET BY PRODUCT

5.1. BRANDED DRUGS
- 5.1.1. MARKET FORECAST FIGURE
- 5.1.2. SEGMENT ANALYSIS
5.2. GENERIC DRUGS
- 5.2.1. MARKET FORECAST FIGURE
- 5.2.2. SEGMENT ANALYSIS
5.3. OTC
- 5.3.1. MARKET FORECAST FIGURE
- 5.3.2. SEGMENT ANALYSIS

6. MARKET BY THERAPY AREA

6.1. COMMUNICABLE DISEASES
- 6.1.1. MARKET FORECAST FIGURE
- 6.1.2. SEGMENT ANALYSIS
6.2. ONCOLOGY
- 6.2.1. MARKET FORECAST FIGURE
- 6.2.2. SEGMENT ANALYSIS
6.3. DIABETES
- 6.3.1. MARKET FORECAST FIGURE
- 6.3.2. SEGMENT ANALYSIS
6.4. CARDIOVASCULAR DISEASES
- 6.4.1. MARKET FORECAST FIGURE
- 6.4.2. SEGMENT ANALYSIS
6.5. AUTOIMMUNE DISEASES
- 6.5.1. MARKET FORECAST FIGURE
- 6.5.2. SEGMENT ANALYSIS
6.6. NEUROLOGICAL DISORDERS
- 6.6.1. MARKET FORECAST FIGURE
- 6.6.2. SEGMENT ANALYSIS
6.7. PAIN MANAGEMENT
- 6.7.1. MARKET FORECAST FIGURE
- 6.7.2. SEGMENT ANALYSIS
6.8. RESPIRATORY DISEASES
- 6.8.1. MARKET FORECAST FIGURE
- 6.8.2. SEGMENT ANALYSIS
6.9. OTHER THERAPY AREAS
- 6.9.1. MARKET FORECAST FIGURE
- 6.9.2. SEGMENT ANALYSIS

7. MARKET BY TYPE

7.1. NON-COLD CHAIN LOGISTICS
- 7.1.1. MARKET FORECAST FIGURE
- 7.1.2. SEGMENT ANALYSIS
7.2. COLD CHAIN LOGISTICS
- 7.2.1. MARKET FORECAST FIGURE
- 7.2.2. SEGMENT ANALYSIS

8. MARKET BY COMPONENT

8.1. STORAGE
- 8.1.1. WAREHOUSE
  - 8.1.1.1. MARKET FORECAST FIGURE
  - 8.1.1.2. SEGMENT ANALYSIS
- 8.1.2. REFRIGERATED CONTAINERS
  - 8.1.2.1. MARKET FORECAST FIGURE
  - 8.1.2.2. SEGMENT ANALYSIS
8.2. TRANSPORTATION
- 8.2.1. OVERLAND LOGISTICS
  - 8.2.1.1. MARKET FORECAST FIGURE
  - 8.2.1.2. SEGMENT ANALYSIS
- 8.2.2. SEA FREIGHT LOGISTICS
  - 8.2.2.1. MARKET FORECAST FIGURE
  - 8.2.2.2. SEGMENT ANALYSIS
- 8.2.3. AIR FREIGHT LOGISTICS
  - 8.2.3.1. MARKET FORECAST FIGURE
  - 8.2.3.2. SEGMENT ANALYSIS
8.3. MONITORING COMPONENTS
- 8.3.1. HARDWARE
  - 8.3.1.1. SENSORS
  - 8.3.1.1.1. MARKET FORECAST FIGURE
  - 8.3.1.1.2. SEGMENT ANALYSIS
  - 8.3.1.2. RFID DEVICES
  - 8.3.1.2.1. MARKET FORECAST FIGURE
  - 8.3.1.2.2. SEGMENT ANALYSIS
  - 8.3.1.3. TELEMATICS
  - 8.3.1.3.1. MARKET FORECAST FIGURE
  - 8.3.1.3.2. SEGMENT ANALYSIS
  - 8.3.1.4. NETWORKING DEVICES
  - 8.3.1.4.1. MARKET FORECAST FIGURE
  - 8.3.1.4.2. SEGMENT ANALYSIS
- 8.3.2. SOFTWARE
  - 8.3.2.1. MARKET FORECAST FIGURE
  - 8.3.2.2. SEGMENT ANALYSIS

9. COMPETITIVE LANDSCAPE

9.1. KEY STRATEGIC DEVELOPMENTS
- 9.1.1. MERGERS & ACQUISITIONS
- 9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 9.1.3. PARTNERSHIPS & AGREEMENTS
- 9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
- 9.2.1. AGILITY LOGISTICS
  - 9.2.1.1. COMPANY OVERVIEW
  - 9.2.1.2. PRODUCT PORTFOLIO
  - 9.2.1.3. STRENGTHS & CHALLENGES
- 9.2.2. AP MOLLER - MAERSK
  - 9.2.2.1. COMPANY OVERVIEW
  - 9.2.2.2. PRODUCT PORTFOLIO
  - 9.2.2.3. STRENGTHS & CHALLENGES
- 9.2.3. CARDINAL HEALTH
  - 9.2.3.1. COMPANY OVERVIEW
  - 9.2.3.2. PRODUCT PORTFOLIO
  - 9.2.3.3. STRENGTHS & CHALLENGES
- 9.2.4. CENCORA (AMERISOURCEBERGEN)
  - 9.2.4.1. COMPANY OVERVIEW
  - 9.2.4.2. PRODUCT PORTFOLIO
  - 9.2.4.3. STRENGTHS & CHALLENGES
- 9.2.5. CEVA LOGISTICS
  - 9.2.5.1. COMPANY OVERVIEW
  - 9.2.5.2. PRODUCT PORTFOLIO
  - 9.2.5.3. STRENGTHS & CHALLENGES
- 9.2.6. DB SCHENKER
  - 9.2.6.1. COMPANY OVERVIEW
  - 9.2.6.2. PRODUCT PORTFOLIO
  - 9.2.6.3. STRENGTHS & CHALLENGES
- 9.2.7. DEUTSCHE POST AG
  - 9.2.7.1. COMPANY OVERVIEW
  - 9.2.7.2. PRODUCT PORTFOLIO
  - 9.2.7.3. STRENGTHS & CHALLENGES
- 9.2.8. DSV
  - 9.2.8.1. COMPANY OVERVIEW
  - 9.2.8.2. PRODUCT PORTFOLIO
  - 9.2.8.3. STRENGTHS & CHALLENGES
- 9.2.9. FEDEX
  - 9.2.9.1. COMPANY OVERVIEW
  - 9.2.9.2. PRODUCT PORTFOLIO
  - 9.2.9.3. STRENGTHS & CHALLENGES
- 9.2.10. KUEHNE + NAGEL
  - 9.2.10.1. COMPANY OVERVIEW
  - 9.2.10.2. PRODUCT PORTFOLIO
  - 9.2.10.3. STRENGTHS & CHALLENGES
- 9.2.11. MARKEN (ACQUIRED BY UPS)
  - 9.2.11.1. COMPANY OVERVIEW
  - 9.2.11.2. PRODUCT PORTFOLIO
  - 9.2.11.3. STRENGTHS & CHALLENGES
- 9.2.12. MEDLINE
  - 9.2.12.1. COMPANY OVERVIEW
  - 9.2.12.2. PRODUCT PORTFOLIO
  - 9.2.12.3. STRENGTHS & CHALLENGES
- 9.2.13. SEKO LOGISTICS
  - 9.2.13.1. COMPANY OVERVIEW
  - 9.2.13.2. PRODUCT PORTFOLIO
  - 9.2.13.3. STRENGTHS & CHALLENGES
- 9.2.14. UNITED PARCEL SERVICE (UPS)
  - 9.2.14.1. COMPANY OVERVIEW
  - 9.2.14.2. PRODUCT PORTFOLIO
  - 9.2.14.3. STRENGTHS & CHALLENGES

Product Code: 85196

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - PHARMACEUTICAL LOGISTICS
TABLE 2: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY PRODUCT, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 4: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY THERAPY AREA, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY THERAPY AREA, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 6: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY TYPE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 8: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY COMPONENT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY COMPONENT, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 10: GERMANY STORAGE MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 11: GERMANY STORAGE MARKET, BY SERVICE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 12: GERMANY TRANSPORTATION MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 13: GERMANY TRANSPORTATION MARKET, BY SERVICE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 14: GERMANY MONITORING COMPONENTS MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 15: GERMANY MONITORING COMPONENTS MARKET, BY SERVICE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 16: GERMANY HARDWARE MARKET, BY HARDWARE TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 17: GERMANY HARDWARE MARKET, BY HARDWARE TYPE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 18: LIST OF MERGERS & ACQUISITIONS
TABLE 19: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 20: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 21: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING FOR GERMANY
FIGURE 4: MARKET CONCENTRATION ANALYSIS
FIGURE 5: VALUE CHAIN ANALYSIS
FIGURE 6: KEY BUYING CRITERIA
FIGURE 7: GERMANY PHARMACEUTICAL LOGISTICS MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2023
FIGURE 8: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY BRANDED DRUGS, 2024-2032 (IN $ MILLION)
FIGURE 9: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY GENERIC DRUGS, 2024-2032 (IN $ MILLION)
FIGURE 10: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY OTC, 2024-2032 (IN $ MILLION)
FIGURE 11: GERMANY PHARMACEUTICAL LOGISTICS MARKET, GROWTH POTENTIAL, BY THERAPY AREA, IN 2023
FIGURE 12: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY COMMUNICABLE DISEASES, 2024-2032 (IN $ MILLION)
FIGURE 13: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY ONCOLOGY, 2024-2032 (IN $ MILLION)
FIGURE 14: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY DIABETES, 2024-2032 (IN $ MILLION)
FIGURE 15: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY CARDIOVASCULAR DISEASES, 2024-2032 (IN $ MILLION)
FIGURE 16: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY AUTOIMMUNE DISEASES, 2024-2032 (IN $ MILLION)
FIGURE 17: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY NEUROLOGICAL DISORDERS, 2024-2032 (IN $ MILLION)
FIGURE 18: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY PAIN MANAGEMENT, 2024-2032 (IN $ MILLION)
FIGURE 19: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY RESPIRATORY DISEASES, 2024-2032 (IN $ MILLION)
FIGURE 20: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY OTHER THERAPY AREAS, 2024-2032 (IN $ MILLION)
FIGURE 21: GERMANY PHARMACEUTICAL LOGISTICS MARKET, GROWTH POTENTIAL, BY TYPE, IN 2023
FIGURE 22: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY NON-COLD CHAIN LOGISTICS, 2024-2032 (IN $ MILLION)
FIGURE 23: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY COLD CHAIN LOGISTICS, 2024-2032 (IN $ MILLION)
FIGURE 24: GERMANY PHARMACEUTICAL LOGISTICS MARKET, GROWTH POTENTIAL, BY COMPONENT, IN 2023
FIGURE 25: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY STORAGE, 2024-2032 (IN $ MILLION)
FIGURE 26: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY WAREHOUSE, 2024-2032 (IN $ MILLION)
FIGURE 27: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY REFRIGERATED CONTAINERS, 2024-2032 (IN $ MILLION)
FIGURE 28: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY TRANSPORTATION, 2024-2032 (IN $ MILLION)
FIGURE 29: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY OVERLAND LOGISTICS, 2024-2032 (IN $ MILLION)
FIGURE 30: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY SEA FREIGHT LOGISTICS, 2024-2032 (IN $ MILLION)
FIGURE 31: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY AIR FREIGHT LOGISTICS, 2024-2032 (IN $ MILLION)
FIGURE 32: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY MONITORING COMPONENTS, 2024-2032 (IN $ MILLION)
FIGURE 33: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY HARDWARE, 2024-2032 (IN $ MILLION)
FIGURE 34: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY SENSORS, 2024-2032 (IN $ MILLION)
FIGURE 35: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY RFID DEVICES, 2024-2032 (IN $ MILLION)
FIGURE 36: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY TELEMATICS, 2024-2032 (IN $ MILLION)
FIGURE 37: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY NETWORKING DEVICES, 2024-2032 (IN $ MILLION)
FIGURE 38: GERMANY PHARMACEUTICAL LOGISTICS MARKET, BY SOFTWARE, 2024-2032 (IN $ MILLION)